The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis
Hench PS, Kendall EC. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc Staff Meet Mayo Clin 1949;24:181-97.
Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions
Hench PS, Kendall EC, Slocumb CH et al. Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions. Arch Intern Med 1950;85:545-666.
Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate
Strand V, Cohen S, Schiff M et al. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. Arch Intern Med 1999;159: 2542-50.
JAK inhibition for the treatment of rheumatoid arthritis: a new era in oral DMARD therapy
Vaddi K, Luchi M. JAK inhibition for the treatment of rheumatoid arthritis: a new era in oral DMARD therapy. Expert Opin Investig Drugs 2012;21: 961-73.
Small molecules targeting JAKs-a new approach in the treatment of rheumatoid arthritis
doi:10.1093/rheumatology/ kes417
Feist E, Burmester GR. Small molecules targeting JAKs-a new approach in the treatment of rheumatoid arthritis. Rheumatology 2013;52:doi:10.1093/rheumatology/ kes417.
Inhibition of spleen tyrosine kinase in the treatment of rheumatoid arthritis
doi:10.1093/rheumatology/ ket225
Nijjar JS, Tindell A, McInnes IB et al. Inhibition of spleen tyrosine kinase in the treatment of rheumatoid arthritis. Rheumatology 2013;52:doi:10.1093/rheumatology/ ket225.